EU/U.S. GMP Inspections Strategy Could Spell Relief for Drugmakers

The European Medicines Agency (EMA) and U.S. Food and Drug Administration (FDA) plan to step up cooperation on good manufacturing practice (GMP) inspections, moving from information-sharing and joint inspections to outright reliance on one another’s results.
International Pharmaceutical Regulatory Monitor